За StandardX
StandardX разработва компактна платформа с мощни ускорители на частици, предназначена да произвежда различни изотопи чрез стандартизирана инсталация. Основана през 2025 г., компанията първоначално се фокусира върху доставките за диагностика и лечение на рак, научни изследвания и бъдещи термоядрени системи.
What StandardX offers
StandardX is developing a scalable production platform for rare isotopes used in medicine, industry and energy. Its compact particle-accelerator architecture is intended to produce a versatile portfolio including diagnostic and therapeutic medical isotopes, industrial isotopes and tritium for fusion energy.
What sets StandardX apart
StandardX is building a repeatable isotope-production platform rather than a facility dedicated to a single isotope. The compact accelerator architecture is designed to translate specialised nuclear physics into distributed, scalable production for materials that are currently scarce or constrained by centralised supply.